<DOC>
	<DOCNO>NCT01062529</DOCNO>
	<brief_summary>The aim study investigate peripheral effect Somatostatin glucose metabolism growth hormone ( GH ) signal healthy men . Eight subject enrol . The hypothesis Somatostatin infusion reverse insulin resistance cause GH .</brief_summary>
	<brief_title>Peripheral Metabolic Effects Somatostatin</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>BMI &lt; 27 kg/m2 Written inform consent Healthy Any disease Any use medication Present previous malignancy Alcohol dependency Allergy trial medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>GH signal</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>somatostatin</keyword>
	<keyword>acromegaly</keyword>
</DOC>